Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.

Abstract

A patient with perforated appendicitis developed progressive vasodilatory shock which was complicated by perioperative acute myocardial infarction. Cardiovascular support included dopamine infusion, and later, intra-aortic balloon counterpulsation balloon pump and noradrenaline and dobutamine infusion. Vasopressin was introduced as a final attempt to reverse the refractory shock and was associated with recovery. The experience with this case suggests that vasopressin may be a valuable adjunct to the treatment of catecholamine-resistant vasodilatory shock.

• Authors: T W Lim, S Lee, K S NG
• Journal: Anaesthesia and intensive care (Anaesth Intensive Care) Vol. 28 Issue 3 Pg. 313-7 (Jun 2000) ISSN: 0310-057X [Print] United States
• PMID: 10853217 (Publication Type: Case Reports, Journal Article)

Chemical References

• Adrenergic alpha-Agonists
• Adrenergic beta-Agonists
• Cardiotonic Agents
• Vasoconstrictor Agents
• Vasopressins
• Dobutamine
• Dopamine
• Norepinephrine

Topics

• Adrenergic alpha-Agonists (administration & dosage, therapeutic use)
• Adrenergic beta-Agonists (administration & dosage, therapeutic use)
• Aged
• Appendicitis (complications)
• Cardiotonic Agents (therapeutic use)
• Dobutamine (administration & dosage, therapeutic use)
• Dopamine (therapeutic use)
• Humans
• Infusions, Intravenous
• Intestinal Perforation (complications)
• Intra-Aortic Balloon Pumping
• Intraoperative Complications
• Male
• Myocardial Infarction (complications)
• Norepinephrine (administration & dosage, therapeutic use)
• Recovery of Function
• Shock (drug therapy, etiology)
• Vasoconstrictor Agents (therapeutic use)
• Vasodilation (drug effects)
• Vasopressins (therapeutic use)